文献速递胰腺与胆道疾病消化内镜

预测重症急性胆源性胰腺炎中经内镜超声筛选紧急内镜逆行胰胆管造影的患者选择(APEC-2):一项多中心前瞻性研究

Patient selection for urgent endoscopic retrograde cholangio-pancreatography by endoscopic ultrasound in predicted severe acute biliary pancreatitis (APEC-2): a multicentre prospective study.
PubMed 文献 · Gut · 2023-02-27

这项多中心前瞻性队列研究纳入无胆管炎的预测重症急性胆源性胰腺炎患者,在就诊24小时内及症状发作72小时内行紧急内镜超声,发现胆管结石/胆泥者行内镜逆行胰胆管造影联合内镜乳头括约肌切开。主要终点为6个月内重大并发症或死亡的复合终点,EUS引导ERCP组发生34/83例(41%),历史保守治疗组为44%(50/113例),风险比0.93(95%CI 0.67-1.29;p=0.65),校正后OR 1.03(95%CI 0.56-1.90;p=0.92),差异无统计学意义。

要点

  • 紧急EUS在就诊中位21小时、症状发作中位29小时完成。
  • EUS检出胆管结石/胆泥48/83例(58%),均行急诊ERCP联合ES。
  • EUS引导ERCP组主要终点41% vs 历史保守组44%,RR 0.93(95%CI 0.67-1.29;p=0.65)。

核心结论

  • 在无胆管炎的预测重症急性胆源性胰腺炎患者中,与历史对照组保守治疗相比,紧急EUS引导的ERCP联合ES未降低重大并发症或死亡的复合终点。

研究设计与样本

  • 多中心前瞻性队列研究,纳入无胆管炎的预测重症急性胆源性胰腺炎患者,均行紧急EUS,检出胆管结石/胆泥者行ERCP联合ES,要求在就诊24小时内及症状发作72小时内完成。
  • 历史对照组为随机APEC试验(急性胆源性胰腺炎:紧急ERCP联合括约肌切开 vs 保守治疗,患者纳入时间2013-2017年)的保守治疗组(n=113),采用相同研究设计。
  • 试验注册号ISRCTN15545919。

主要发现

  • 共83例患者行紧急EUS,就诊后中位21小时(IQR 17-23)、症状发作后中位29小时(IQR 23-41)完成。
  • EUS检出胆管结石/胆泥48/83例(58%),均立即行ERCP联合ES。
  • EUS引导ERCP组主要终点发生34/83例(41%),历史保守治疗组为44%(50/113例),风险比0.93(95%CI 0.67-1.29;p=0.65)。
  • 采用逻辑回归模型校正基线差异的敏感性分析显示干预对主要结局无显著有益效应(校正OR 1.03,95%CI 0.56-1.90;p=0.92)。

临床怎么用

  • 原文未据此给出推荐;作者结论为紧急EUS引导的ERCP联合ES与历史保守治疗相比未降低复合终点。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Routine urgent endoscopic retrograde cholangiopancreatography (ERCP) with endoscopic biliary sphincterotomy (ES) does not improve outcome in patients with predicted severe acute biliary pancreatitis. Improved patient selection for ERCP by means of endoscopic ultrasonography (EUS) for stone/sludge detection may challenge these findings. DESIGN: A multicentre, prospective cohort study included patients with predicted severe acute biliary pancreatitis without cholangitis. Patients underwent urgent EUS, followed by ERCP with ES in case of common bile duct stones/sludge, within 24 hours after hospital presentation and within 72 hours after symptom onset. The primary endpoint was a composite of major complications or mortality within 6 months after inclusion. The historical control group was the conservative treatment arm (n=113) of the randomised APEC trial (Acute biliary Pancreatitis: urgent ERCP with sphincterotomy versus conservative treatment, patient inclusion 2013-2017) applying the same study design. RESULTS: Overall, 83 patients underwent urgent EUS at a median of 21 hours (IQR 17-23) after hospital presentation and at a median of 29 hours (IQR 23-41) after start of symptoms. Gallstones/sludge in the bile ducts were detected by EUS in 48/83 patients (58%), all of whom underwent immediate ERCP with ES. The primary endpoint occurred in 34/83 patients (41%) in the urgent EUS-guided ERCP group. This was not different from the 44% rate (50/113 patients) in the historical conservative treatment group (risk ratio (RR) 0.93, 95% CI 0.67 to 1.29; p=0.65). Sensitivity analysis to correct for baseline differences using a logistic regression model also showed no significant beneficial effect of the intervention on the primary outcome (adjusted OR 1.03, 95% CI 0.56 to 1.90, p=0.92). CONCLUSION: In patients with predicted severe acute biliary pancreatitis without cholangitis, urgent EUS-guided ERCP with ES did not reduce the composite endpoint of major complications or mortality, as compared with conservative treatment in a historical control group. TRIAL REGISTRATION NUMBER: ISRCTN15545919.

来源:Gut,查看原文。版权归原作者所有。

引用

  1. Hallensleben ND, Stassen PMC, Schepers NJ, et al. Patient selection for urgent endoscopic retrograde cholangio-pancreatography by endoscopic ultrasound in predicted severe acute biliary pancreatitis (APEC-2): a multicentre prospective study. Gut. 2023. PMID: 36849226. doi:10.1136/gutjnl-2022-328258

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。